Clinical Trial: Utilization of Residual Donor Tissue for Regrafting in Bullous Keratopathy After Corneal Transplantation

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07855601) titled 'Utilization of Residual Donor Tissue for Regrafting in Bullous Keratopathy After Corneal Transplantation' on Sept. 28.

Brief Summary: Postoperative endothelial cell loss following Descemet stripping endothelial keratoplasty (DSEK) remains a well-recognized clinical concern, with long-term follow-up demonstrating approximately 50% reduction in endothelial cell density by 5 years. Compounding this challenge, the critical shortage of corneal donors has severely limited the expansion of corneal transplantation programs in developing countries. In conventional penetrating keratoplasty, only the central 7-mm optical zone is typically harve...